Renegotiating a Price

Executive Summary

Companies in both the Statutory and Voluntary Schemes may renegotiate a price with the Department for Health and Social Care (DHSC). The renegotiation process is the same for all drugs on both schemes, except for new active substances (NAS) in the Voluntary Scheme. This page guides companies through the pricing negotiations process, detailing the key criteria companies must meet in order for a successful application, complete with insights and downloadable templates.